Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas

10.3390/cancers10040089

Saved in:

Bibliographic Details
Main Authors:	Ramayanti, O, Brinkkemper, M, Verkuijlen, S.A.W.M, Ritmaleni, L, Go, M.L, Middeldorp, J.M
Other Authors:	PHARMACY
Format:	Article
Published:	2020
Subjects:	3,5 bis(2 fluorobenzylidene) 4 piperidinone antineoplastic agent curcumin curcuminoid gemcitabine messenger RNA monoclonal antibody unclassified drug valproic acid Article cancer adjuvant therapy carcinoma concentration response controlled study cytotoxicity drug potentiation Epstein Barr virus gastric carcinoma cell line human human cell immunoblotting immunofluorescence nasopharyngeal carcinoma cell line nonhuman virus reactivation virus replication
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178248
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-178248
record_format	dspace
spelling	sg-nus-scholar.10635-1782482024-11-10T08:55:07Z Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas Ramayanti, O Brinkkemper, M Verkuijlen, S.A.W.M Ritmaleni, L Go, M.L Middeldorp, J.M PHARMACY 3,5 bis(2 fluorobenzylidene) 4 piperidinone antineoplastic agent curcumin curcuminoid gemcitabine messenger RNA monoclonal antibody unclassified drug valproic acid Article cancer adjuvant therapy carcinoma concentration response controlled study cytotoxicity drug potentiation Epstein Barr virus gastric carcinoma cell line human human cell immunoblotting immunofluorescence nasopharyngeal carcinoma cell line nonhuman virus reactivation virus replication 10.3390/cancers10040089 Cancers 10 4 89 2020-10-20T08:53:22Z 2020-10-20T08:53:22Z 2018 Article Ramayanti, O, Brinkkemper, M, Verkuijlen, S.A.W.M, Ritmaleni, L, Go, M.L, Middeldorp, J.M (2018). Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas. Cancers 10 (4) : 89. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers10040089 20726694 https://scholarbank.nus.edu.sg/handle/10635/178248 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	3,5 bis(2 fluorobenzylidene) 4 piperidinone antineoplastic agent curcumin curcuminoid gemcitabine messenger RNA monoclonal antibody unclassified drug valproic acid Article cancer adjuvant therapy carcinoma concentration response controlled study cytotoxicity drug potentiation Epstein Barr virus gastric carcinoma cell line human human cell immunoblotting immunofluorescence nasopharyngeal carcinoma cell line nonhuman virus reactivation virus replication
spellingShingle	3,5 bis(2 fluorobenzylidene) 4 piperidinone antineoplastic agent curcumin curcuminoid gemcitabine messenger RNA monoclonal antibody unclassified drug valproic acid Article cancer adjuvant therapy carcinoma concentration response controlled study cytotoxicity drug potentiation Epstein Barr virus gastric carcinoma cell line human human cell immunoblotting immunofluorescence nasopharyngeal carcinoma cell line nonhuman virus reactivation virus replication Ramayanti, O Brinkkemper, M Verkuijlen, S.A.W.M Ritmaleni, L Go, M.L Middeldorp, J.M Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
description	10.3390/cancers10040089
author2	PHARMACY
author_facet	PHARMACY Ramayanti, O Brinkkemper, M Verkuijlen, S.A.W.M Ritmaleni, L Go, M.L Middeldorp, J.M
format	Article
author	Ramayanti, O Brinkkemper, M Verkuijlen, S.A.W.M Ritmaleni, L Go, M.L Middeldorp, J.M
author_sort	Ramayanti, O
title	Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
title_short	Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
title_full	Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
title_fullStr	Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
title_full_unstemmed	Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
title_sort	curcuminoids as ebv lytic activators for adjuvant treatment in ebv-positive carcinomas
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/178248
_version_	1821203865490423808

Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas

Similar Items